Bioequivalence of saxagliptin/dapagliflozin fixed‐dose combination tablets compared with coadministration of the individual tablets to healthy subjects

Saxagliptin and dapagliflozin are individually indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. The bioequivalence of saxagliptin/dapagliflozin 2.5/5 mg and 5/10 mg fixed‐dose combination (FDC) tablets compared with coadministration of...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Pharmacol Res Perspect
Main Authors: Vakkalagadda, Blisse, Vetter, Marion L., Rana, Jignasa, Smith, Charles H., Huang, Jian, Karkas, Jennifer, Boulton, David W., LaCreta, Frank
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2016
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4777251/
https://ncbi.nlm.nih.gov/pubmed/27022473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.201
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares